- Home
- PRAX vs SWIM Comparison
PRAX vs SWIM Comparison
Compare PRAX & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- SWIM
- Stock Information
- Founded
- PRAX 2015
- SWIM 1956
- Country
- PRAX United States
- SWIM United States
- Employees
- PRAX N/A
- SWIM N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- SWIM Plastic Products
- Sector
- PRAX Health Care
- SWIM Industrials
- Exchange
- PRAX Nasdaq
- SWIM Nasdaq
- Market Cap
- PRAX 950.8M
- SWIM 885.7M
- IPO Year
- PRAX 2020
- SWIM 2021
- Fundamental
- Price
- PRAX $46.85
- SWIM $8.24
- Analyst Decision
- PRAX Strong Buy
- SWIM Hold
- Analyst Count
- PRAX 9
- SWIM 3
- Target Price
- PRAX $94.44
- SWIM $6.93
- AVG Volume (30 Days)
- PRAX 388.4K
- SWIM 649.2K
- Earning Date
- PRAX 08-04-2025
- SWIM 11-04-2025
- Dividend Yield
- PRAX N/A
- SWIM N/A
- EPS Growth
- PRAX N/A
- SWIM N/A
- EPS
- PRAX N/A
- SWIM N/A
- Revenue
- PRAX $7,765,000.00
- SWIM $521,828,000.00
- Revenue This Year
- PRAX N/A
- SWIM $9.17
- Revenue Next Year
- PRAX $25.00
- SWIM $5.38
- P/E Ratio
- PRAX N/A
- SWIM N/A
- Revenue Growth
- PRAX 338.45
- SWIM N/A
- 52 Week Low
- PRAX $26.70
- SWIM $4.56
- 52 Week High
- PRAX $91.83
- SWIM $8.46
- Technical
- Relative Strength Index (RSI)
- PRAX 47.63
- SWIM 63.58
- Support Level
- PRAX $44.13
- SWIM $7.68
- Resistance Level
- PRAX $47.06
- SWIM $8.46
- Average True Range (ATR)
- PRAX 2.18
- SWIM 0.29
- MACD
- PRAX 0.05
- SWIM -0.03
- Stochastic Oscillator
- PRAX 54.73
- SWIM 79.44
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.